Welgene Biotech Co., Ltd.(TW:6661)
NT$16.000.00 (0.00%)
TW:6661
Welgene Biotech Co., Ltd. financials statements
NT$16.00
At close:0.00 (0.00%)
Welgene Biotech Co., Ltd. (6661) Income Statement
Welgene Biotech Co., Ltd. Income Statement
Last quarter (Q2 2026), Welgene Biotech Co., Ltd.'s total revenue was NT$107.21M, an increase of 18.98% from the same quarter last year. In Q2, Welgene Biotech Co., Ltd.'s net income was NT$-1.71M. See Welgene Biotech Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 375.94M | NT$ 322.55M | NT$ 280.55M | NT$ 321.90M | NT$ 312.65M | |
| NT$ 129.27M | NT$ 135.84M | NT$ 119.72M | NT$ 141.80M | NT$ 133.27M | |
| NT$ 129.15M | NT$ 136.54M | NT$ 123.97M | NT$ 125.93M | NT$ 118.56M | |
| Depreciation and Amortization | NT$ 27.79M | NT$ 28.80M | NT$ 27.25M | NT$ 19.05M | NT$ 19.21M |
| NT$ 27.92M | NT$ 33.01M | NT$ 26.84M | NT$ 35.66M | NT$ 39.12M | |
| NT$ 127.00K | NT$ -704.00K | NT$ -4.26M | NT$ 16.61M | NT$ 12.17M | |
| NT$ 1.21M | NT$ 2.10M | NT$ 1.23M | NT$ -3.74M | NT$ 2.08M | |
| NT$ 1.34M | NT$ 1.25M | NT$ -3.03M | NT$ 13.55M | NT$ 16.60M | |
| NT$ 1.33M | NT$ 1.11M | NT$ -2.65M | NT$ 9.55M | NT$ 13.70M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 0.06 | NT$ 0.05 | NT$ -0.11 | NT$ 0.41 | NT$ 0.59 |
| Diluted EPS | NT$ 0.06 | NT$ 0.05 | NT$ -0.11 | NT$ 0.41 | NT$ 0.59 |
| Weighted Average Shares Outstanding | 23.30M | 23.30M | 23.30M | 23.30M | 23.09M |
| Weighted Average Shares Outstanding (Diluted) | 23.30M | 23.30M | 23.30M | 23.33M | 23.11M |
Currency in TWD
